Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies
出版年份 2013 全文链接
标题
Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies
作者
关键词
-
出版物
CURRENT MEDICAL RESEARCH AND OPINION
Volume 30, Issue 5, Pages 775-784
出版商
Informa Healthcare
发表日期
2013-12-12
DOI
10.1185/03007995.2013.874989
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
- (2013) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients
- (2013) Maki Miyamoto-Sasaki et al. Journal of Atherosclerosis and Thrombosis
- Risk of incident diabetes among patients treated with statins: population based study
- (2013) A. A. Carter et al. BMJ-British Medical Journal
- Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance
- (2012) J. Boon et al. DIABETES
- Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
- (2012) Paul M Ridker et al. LANCET
- The emerging role of HDL in glucose metabolism
- (2012) Brian G. Drew et al. Nature Reviews Endocrinology
- Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia
- (2012) Steen Stender et al. European Journal of Preventive Cardiology
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
- (2012) European Journal of Preventive Cardiology
- Long-term efficacy of pitavastatin versus simvastatin
- (2011) Mats Eriksson et al. ADVANCES IN THERAPY
- Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial
- (2011) Mats Eriksson et al. ADVANCES IN THERAPY
- Are statins diabetogenic?
- (2011) Uchechukwu K Sampson et al. CURRENT OPINION IN CARDIOLOGY
- Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia
- (2011) J. Gumprecht et al. DIABETES OBESITY & METABOLISM
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
- (2011) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia
- (2009) Leiv Ose et al. ATHEROSCLEROSIS
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
- (2009) William L. Baker et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug–drug interaction with statins
- (2008) Alberto Corsini et al. Expert Review of Clinical Pharmacology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now